Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
CC transcript
Director departure
Inv. presentation
|
|
Orexigen Therapeutics, Inc. (OREXQ)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/01/2017 |
10-K/A
| Annual Report for the period ended December 31, 2016 [amend] |
| 03/29/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
| 04/29/2016 |
10-K/A
| Annual Report for the period ended December 31, 2015 [amend] |
| 02/26/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
| 02/27/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
| 01/26/2015 |
10-K/A
| Annual Report for the period ended December 31, 2013 [amend] |
| 03/13/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
| 03/14/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
| 03/13/2012 |
10-K
| Annual Report for the period ended December 31, 2011 |
| 03/11/2011 |
10-K
| Annual Report for the period ended December 31, 2010 |
| 03/11/2010 |
10-K
| Annual Report for the period ended December 31, 2009 |
| 03/13/2009 |
10-K
| Annual Report for the period ended December 31, 2008 |
| 03/27/2008 |
10-K
| Annual Report for the period ended December 31, 2007 |
|
|